Erratum: Corrigendum to “In vitro, molecular modeling and behavioral studies of ‘3-{[4-(5-methoxy-1H-indol-3-yl)-1,2,3,6-tetrahydropyridin-1-yl]methyl}-1,2-dihydroquinolin-2-one (D2AAK1) as a potential antipsychotic” (Neurochemistry International (2016) 96 (84–99)(10.1016/j.neuint.2016.03.003)(S0197018616300304))

1. Kaczor, A.A.
2. Targowska-Duda, K.M.
3. Budzyńska, B.
4. Biała, G.
5. Silva, A.G.
6. Castro, M.